As healthcare systems increasingly shift from treatment to prevention, legal frameworks play a critical role in enabling innovation in preventive health and longevity. This panel will examine how regulation, policy and compliance shape the development and adoption of preventive healthcare models, including early diagnostics, digital health and longevity-focused interventions. Speakers will explore the legal and ethical challenges surrounding personalised medicine, data use, clinical validation and cross-border care in life sciences. The discussion will also address ethical considerations such as fair access to healthcare and patient protection in rapidly evolving preventive and longevity markets. By bringing together legal and healthcare perspectives, the panel will highlight how law can act as a catalyst for sustainable, preventive and longer-life-focused health systems.
12th Annual IBA World Life Sciences Conference